A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol

Peer Review reports

Original Submission
23 Aug 2013	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
1 Oct 2013	Reviewed	Reviewer Report - Christopher Adlbrecht
30 Oct 2013	Author responded	Author comments - Claire Foley
Resubmission - Version 3
30 Oct 2013	Submitted	Manuscript version 3
12 Nov 2013	Author responded	Author comments - Claire Foley
Resubmission - Version 4
12 Nov 2013	Submitted	Manuscript version 4
Publishing
13 Nov 2013	Editorially accepted
1 Dec 2013	Article published	10.1186/1745-6215-14-408

Back to article page